Sunshine Biopharma (SBFM) Retained Earnings (2016 - 2025)
Historic Retained Earnings for Sunshine Biopharma (SBFM) over the last 14 years, with Q3 2025 value amounting to -$72.9 million.
- Sunshine Biopharma's Retained Earnings fell 896.01% to -$72.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$72.9 million, marking a year-over-year decrease of 896.01%. This contributed to the annual value of -$69.0 million for FY2024, which is 803.39% down from last year.
- As of Q3 2025, Sunshine Biopharma's Retained Earnings stood at -$72.9 million, which was down 896.01% from -$72.0 million recorded in Q2 2025.
- Sunshine Biopharma's Retained Earnings' 5-year high stood at -$26.4 million during Q1 2021, with a 5-year trough of -$72.9 million in Q3 2025.
- Its 5-year average for Retained Earnings is -$53.5 million, with a median of -$62.0 million in 2023.
- In the last 5 years, Sunshine Biopharma's Retained Earnings tumbled by 8189.95% in 2022 and then crashed by 593.45% in 2024.
- Quarter analysis of 5 years shows Sunshine Biopharma's Retained Earnings stood at -$32.7 million in 2021, then crashed by 81.9% to -$59.4 million in 2022, then fell by 7.59% to -$63.9 million in 2023, then dropped by 8.03% to -$69.0 million in 2024, then decreased by 5.55% to -$72.9 million in 2025.
- Its Retained Earnings was -$72.9 million in Q3 2025, compared to -$72.0 million in Q2 2025 and -$70.2 million in Q1 2025.